RecruitingOBSERVATIONAL

DiGESTnewborn Study

This study, called DiGESTnewborn, is designed to understand how a mother's blood sugar levels during pregnancy might affect her baby's blood sugar right after they're born. It's a look at information for mothers and their babies who are already taking part in another study called the DiGest Trial. We're interested in conditions like gestational diabetes (a type of diabetes that can develop during pregnancy) and low blood sugar in babies. By carefully observing the sugar levels, researchers hope to gain more knowledge about what helps babies keep their sugar levels healthy after birth. There are no new treatments or medications given as part of this specific study; it mainly involves collecting and analysing information from existing participants.

At a glance

Status

Recruiting

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Enrolment target

Start

01 Sep 2020

Estimated completion

31 Dec 2026

GDM Hypoglycemia

What is this study about?

The DiGESTnewborn Study is looking into an important question: how does a mother's blood sugar control during her pregnancy influence her baby's blood sugar control once the baby is born? We know that some mothers might have conditions like gestational diabetes, where their blood sugar levels are higher than usual during pregnancy. This study aims to understand the connection between these maternal sugar levels and whether a baby might experience low blood sugar (hypoglycemia) after birth.

Researchers will be collecting and analysing information from mothers and their babies who are already part of another study called the DiGest Trial. By doing this, they can look at existing data without needing to do new tests or give any new treatments. The goal is to learn more about how to best support babies' health right after they are born, particularly concerning their blood sugar levels.

Understanding this link is very important because keeping a newborn's blood sugar stable is crucial for their health and development. The findings from this study could help doctors and nurses provide even better care for pregnant women and their babies in the future, ultimately leading to healthier outcomes for newborns.

Key takeaways

This study looks at how a mother's blood sugar in pregnancy affects her baby's blood sugar.
It's for mothers and babies already in the DiGest Trial.
No new tests, treatments, or hospital visits are needed for this study.
Researchers will use existing information to learn more.
Findings could help improve care for future mothers and babies.

Who may be eligible?

To be able to take part in the DiGESTnewborn Study, you and your baby must already be enrolled in another research study called the DiGest Trial. If you joined the DiGest Trial and agreed to take part, then you might be eligible for this follow-up study.

There are no other specific requirements or reasons why you might not be able to join this study. If you are already a participant in the DiGest Trial then you automatically qualify.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

I am a mother.
My baby is born.
I and my baby are already enrolled in the DiGest Trial.
I have given informed consent to be part of the DiGest Trial.

Answer every question to see your result.

What does participation involve?

If you are already part of the DiGest Trial, taking part in the DiGESTnewborn Study simply means that the researchers will use information that has already been collected from you and your baby. This study does not involve any additional visits, medical assessments, or new medications for you or your baby. It's an observational study, which means researchers are looking at existing data to learn more.

Potential risks and benefits

Because you are already involved in the DiGest Trial and this study only uses information already collected, there are no new risks involved for you or your baby. This study does not involve any new procedures or treatments. The potential benefit is that the information gathered will help doctors and researchers better understand newborn health and improve care for future mothers and babies. You always have the right to withdraw your consent for your data to be used, even if you previously agreed, by speaking to the study team.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Addenbrookes Hospital
Verified postcode
Cambridge, United Kingdom· Recruiting

Common questions

What is the main goal of this study?

The goal is to understand how a mother's sugar levels during pregnancy affect her baby's sugar levels after birth.

Do I need to do anything extra if I join?

No, this study uses information already collected from you and your baby from the DiGest Trial, so you won't need to do anything new.

Who can take part in this study?

Only mothers and babies already participating in the DiGest Trial can be part of this study.

Will my baby get any new medicine?

No, this study does not involve giving any new medicines or treatments.

Why is this study important?

It's important because it helps us learn more about how to keep babies healthy, especially regarding their blood sugar levels after birth.

How to find out more

kathryn beardsall

kb274@cam.ac.uk 07565964631 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.